Global and United States Trastuzumab Biosimilar Market Insights, Forecast to 2031

Report ID: 1127794 | Published Date: Jan 2025 | No. of Page: 144 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Trastuzumab Biosimilar Product Introduction
    1.2 Market by Type
        1.2.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Type
        1.2.2 Adjuvant Breast Cancer
        1.2.3 Metastatic Breast Cancer
        1.2.4 Metastatic Gastric Cancer
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Application
        1.3.2 Hospital Pharmacy
        1.3.3 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered

2 Executive Summary
    2.1 Global Trastuzumab Biosimilar Market Size, Estimates and Forecasts
        2.1.1 Global Trastuzumab Biosimilar Revenue 2016-2027
        2.1.2 Global Trastuzumab Biosimilar Sales 2016-2027
    2.2 Global Trastuzumab Biosimilar, Market Size by Region: 2016 VS 2021 VS 2027
    2.3 Trastuzumab Biosimilar Historical Market Size by Region (2016-2021)
        2.3.1 Global Trastuzumab Biosimilar Retrospective Market Scenario in Sales by Region: 2016-2021
        2.3.2 Global Trastuzumab Biosimilar Retrospective Market Scenario in Revenue by Region: 2016-2021
    2.4 Trastuzumab Biosimilar Market Estimates and Projections by Region (2022-2027)
        2.4.1 Global Trastuzumab Biosimilar Sales Forecast by Region (2022-2027)
        2.4.2 Global Trastuzumab Biosimilar Revenue Forecast by Region (2022-2027)

3 Global Trastuzumab Biosimilar Competitor Landscape by Players
    3.1 Global Top Trastuzumab Biosimilar Manufacturers by Sales
        3.1.1 Global Trastuzumab Biosimilar Sales by Manufacturer (2016-2021)
        3.1.2 Global Trastuzumab Biosimilar Sales Market Share by Manufacturer (2016-2021)
    3.2 Global Top Trastuzumab Biosimilar Manufacturers by Revenue
        3.2.1 Key Trastuzumab Biosimilar Manufacturers Covered: Ranking by Revenue
        3.2.2 Global Trastuzumab Biosimilar Revenue by Manufacturers (2016-2021)
        3.2.3 Global Trastuzumab Biosimilar Revenue Share by Manufacturers (2016-2021)
        3.2.4 Global Trastuzumab Biosimilar Market Concentration Ratio (CR5 and HHI) (2016-2021)
        3.2.5 Global Top 10 and Top 5 Companies by Trastuzumab Biosimilar Revenue in 2020
        3.2.6 Global Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Trastuzumab Biosimilar Price by Manufacturers
    3.4 Global Trastuzumab Biosimilar Manufacturing Base Distribution, Product Types
        3.4.1 Trastuzumab Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Trastuzumab Biosimilar Product Type
        3.4.3 Date of International Manufacturers Enter into Trastuzumab Biosimilar Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2027)
    4.1 Global Trastuzumab Biosimilar Market Size by Type (2016-2021)
        4.1.1 Global Trastuzumab Biosimilar Sales by Type (2016-2021)
        4.1.2 Global Trastuzumab Biosimilar Revenue by Type (2016-2021)
        4.1.3 Trastuzumab Biosimilar Average Selling Price (ASP) by Type (2016-2021)
    4.2 Global Trastuzumab Biosimilar Market Size Forecast by Type (2022-2027)
        4.2.1 Global Trastuzumab Biosimilar Sales Forecast by Type (2022-2027)
        4.2.2 Global Trastuzumab Biosimilar Revenue Forecast by Type (2022-2027)
        4.2.3 Trastuzumab Biosimilar Average Selling Price (ASP) Forecast by Type (2022-2027)

5 Breakdown Data by Application (2016-2027)
    5.1 Global Trastuzumab Biosimilar Market Size by Application (2016-2021)
        5.1.1 Global Trastuzumab Biosimilar Sales by Application (2016-2021)
        5.1.2 Global Trastuzumab Biosimilar Revenue by Application (2016-2021)
        5.1.3 Trastuzumab Biosimilar Price by Application (2016-2021)
    5.2 Trastuzumab Biosimilar Market Size Forecast by Application (2022-2027)
        5.2.1 Global Trastuzumab Biosimilar Sales Forecast by Application (2022-2027)
        5.2.2 Global Trastuzumab Biosimilar Revenue Forecast by Application (2022-2027)
        5.2.3 Global Trastuzumab Biosimilar Price Forecast by Application (2022-2027)

6 United States by Players, Type and Application
    6.1 United States Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
        6.1.1 United States Trastuzumab Biosimilar Sales YoY Growth 2016-2027
        6.1.2 United States Trastuzumab Biosimilar Revenue YoY Growth 2016-2027
        6.1.3 United States Trastuzumab Biosimilar Market Share in Global Market 2016-2027
    6.2 United States Trastuzumab Biosimilar Market Size by Players (International and Local Players)
        6.2.1 United States Top Trastuzumab Biosimilar Players by Sales (2016-2021)
        6.2.2 United States Top Trastuzumab Biosimilar Players by Revenue (2016-2021)
    6.3 United States Trastuzumab Biosimilar Historic Market Review by Type (2016-2021)
        6.3.1 United States Trastuzumab Biosimilar Sales Market Share by Type (2016-2021)
        6.3.2 United States Trastuzumab Biosimilar Revenue Market Share by Type (2016-2021)
        6.3.3 United States Trastuzumab Biosimilar Price by Type (2016-2021)
    6.4 United States Trastuzumab Biosimilar Market Estimates and Forecasts by Type (2022-2027)
        6.4.1 United States Trastuzumab Biosimilar Sales Forecast by Type (2022-2027)
        6.4.2 United States Trastuzumab Biosimilar Revenue Forecast by Type (2022-2027)
        6.4.3 United States Trastuzumab Biosimilar Price Forecast by Type (2022-2027)
    6.5 United States Trastuzumab Biosimilar Historic Market Review by Application (2016-2021)
        6.5.1 United States Trastuzumab Biosimilar Sales Market Share by Application (2016-2021)
        6.5.2 United States Trastuzumab Biosimilar Revenue Market Share by Application (2016-2021)
        6.5.3 United States Trastuzumab Biosimilar Price by Application (2016-2021)
    6.6 United States Trastuzumab Biosimilar Market Estimates and Forecasts by Application (2022-2027)
        6.6.1 United States Trastuzumab Biosimilar Sales Forecast by Application (2022-2027)
        6.6.2 United States Trastuzumab Biosimilar Revenue Forecast by Application (2022-2027)
        6.6.3 United States Trastuzumab Biosimilar Price Forecast by Application (2022-2027)

7 North America
    7.1 North America Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
    7.2 North America Trastuzumab Biosimilar Market Facts & Figures by Country
        7.2.1 North America Trastuzumab Biosimilar Sales by Country (2016-2021)
        7.2.2 North America Trastuzumab Biosimilar Revenue by Country (2016-2021)
        7.2.3 United States
        7.2.4 Canada

8 Asia Pacific
    8.1 Asia Pacific Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
    8.2 Asia Pacific Trastuzumab Biosimilar Market Facts & Figures by Region
        8.2.1 Asia Pacific Trastuzumab Biosimilar Sales by Region (2016-2021)
        8.2.2 Asia Pacific Trastuzumab Biosimilar Revenue by Region (2016-2021)
        8.2.3 China
        8.2.4 Japan
        8.2.5 South Korea
        8.2.6 India
        8.2.7 Australia
        8.2.8 Australia
        8.2.9 Indonesia
        8.2.10 Thailand
        8.2.11 Malaysia

9 Europe
    9.1 Europe Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
    9.2 Europe Trastuzumab Biosimilar Market Facts & Figures by Country
        9.2.1 Europe Trastuzumab Biosimilar Sales by Country (2016-2021)
        9.2.2 Europe Trastuzumab Biosimilar Revenue by Country (2016-2021)
        9.2.3 Germany
        9.2.4 France
        9.2.5 U.K.
        9.2.6 Italy

10 Latin America
    10.1 Latin America Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
    10.2 Latin America Trastuzumab Biosimilar Market Facts & Figures by Country
        10.2.1 Latin America Trastuzumab Biosimilar Sales by Country (2016-2021)
        10.2.2 Latin America Trastuzumab Biosimilar Revenue by Country (2016-2021)
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Trastuzumab Biosimilar Market Size YoY Growth 2016-2027
    11.2 Middle East and Africa Trastuzumab Biosimilar Market Facts & Figures by Country
        11.2.1 Middle East and Africa Trastuzumab Biosimilar Sales by Country (2016-2021)
        11.2.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2016-2021)
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 UAE

12 Company Profiles
    12.1 Amgen Inc.
        12.1.1 Amgen Inc. Corporation Information
        12.1.2 Amgen Inc. Description and Business Overview
        12.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Amgen Inc. Trastuzumab Biosimilar Products Offered
        12.1.5 Amgen Inc. Recent Development
    12.2 Pfizer Inc
        12.2.1 Pfizer Inc Corporation Information
        12.2.2 Pfizer Inc Description and Business Overview
        12.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 Pfizer Inc Trastuzumab Biosimilar Products Offered
        12.2.5 Pfizer Inc Recent Development
    12.3 Samsung Bioepis
        12.3.1 Samsung Bioepis Corporation Information
        12.3.2 Samsung Bioepis Description and Business Overview
        12.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Samsung Bioepis Trastuzumab Biosimilar Products Offered
        12.3.5 Samsung Bioepis Recent Development
    12.4 Merck & Co.
        12.4.1 Merck & Co. Corporation Information
        12.4.2 Merck & Co. Description and Business Overview
        12.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 Merck & Co. Trastuzumab Biosimilar Products Offered
        12.4.5 Merck & Co. Recent Development
    12.5 Biocon Limited
        12.5.1 Biocon Limited Corporation Information
        12.5.2 Biocon Limited Description and Business Overview
        12.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Biocon Limited Trastuzumab Biosimilar Products Offered
        12.5.5 Biocon Limited Recent Development
    12.6 Teva Pharmaceutical
        12.6.1 Teva Pharmaceutical Corporation Information
        12.6.2 Teva Pharmaceutical Description and Business Overview
        12.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Products Offered
        12.6.5 Teva Pharmaceutical Recent Development
    12.7 Genentech
        12.7.1 Genentech Corporation Information
        12.7.2 Genentech Description and Business Overview
        12.7.3 Genentech Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 Genentech Trastuzumab Biosimilar Products Offered
        12.7.5 Genentech Recent Development
    12.8 Mundipharma
        12.8.1 Mundipharma Corporation Information
        12.8.2 Mundipharma Description and Business Overview
        12.8.3 Mundipharma Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Mundipharma Trastuzumab Biosimilar Products Offered
        12.8.5 Mundipharma Recent Development
    12.9 Celltrion
        12.9.1 Celltrion Corporation Information
        12.9.2 Celltrion Description and Business Overview
        12.9.3 Celltrion Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 Celltrion Trastuzumab Biosimilar Products Offered
        12.9.5 Celltrion Recent Development
    12.10 Henlius
        12.10.1 Henlius Corporation Information
        12.10.2 Henlius Description and Business Overview
        12.10.3 Henlius Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 Henlius Trastuzumab Biosimilar Products Offered
        12.10.5 Henlius Recent Development
    12.11 Amgen Inc.
        12.11.1 Amgen Inc. Corporation Information
        12.11.2 Amgen Inc. Description and Business Overview
        12.11.3 Amgen Inc. Trastuzumab Biosimilar Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Amgen Inc. Trastuzumab Biosimilar Products Offered
        12.11.5 Amgen Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Trastuzumab Biosimilar Industry Trends
    13.2 Trastuzumab Biosimilar Market Drivers
    13.3 Trastuzumab Biosimilar Market Challenges
    13.4 Trastuzumab Biosimilar Market Restraints

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Trastuzumab Biosimilar Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer
List of Tables
    Table 1. Global Trastuzumab Biosimilar Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Adjuvant Breast Cancer
    Table 3. Major Manufacturers of Metastatic Breast Cancer
    Table 4. Major Manufacturers of Metastatic Gastric Cancer
    Table 5. Major Manufacturers of Others
    Table 6. Global Trastuzumab Biosimilar Market Size Growth Rate by Application (2021-2027) & (K Units)
    Table 7. Global Trastuzumab Biosimilar Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
    Table 8. Global Trastuzumab Biosimilar Sales by Regions (2016-2021) & (K Units)
    Table 9. Global Trastuzumab Biosimilar Sales Market Share by Regions (2016-2021)
    Table 10. Global Trastuzumab Biosimilar Revenue by Regions (2016-2021) & (US$ Million)
    Table 11. Global Trastuzumab Biosimilar Sales Forecast by Region (2022-2027) & (K Units)
    Table 12. Global Trastuzumab Biosimilar Sales Market Share Forecast by Region (2022-2027)
    Table 13. Global Trastuzumab Biosimilar Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 14. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Region (2022-2027)
    Table 15. Global Trastuzumab Biosimilar Sales by Manufacturers (2016-2021) (K Units)
    Table 16. Global Trastuzumab Biosimilar Sales Share by Manufacturers (2016-2021)
    Table 17. Ranking of Global Top Trastuzumab Biosimilar Manufacturers by Revenue (US$ Million) in 2020
    Table 18. Trastuzumab Biosimilar Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 19. Trastuzumab Biosimilar Revenue Share by Manufacturers (2016-2021)
    Table 20. Global Trastuzumab Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 21. Global Trastuzumab Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Trastuzumab Biosimilar as of 2020)
    Table 22. Key Manufacturers Trastuzumab Biosimilar Price (2016-2021) (US$/Unit)
    Table 23. Trastuzumab Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Trastuzumab Biosimilar Product Type
    Table 25. Date of International Manufacturers Enter into Trastuzumab Biosimilar Market
    Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 27. Global Trastuzumab Biosimilar Sales by Type (2016-2021) (K Units)
    Table 28. Global Trastuzumab Biosimilar Sales Share by Type (2016-2021)
    Table 29. Global Trastuzumab Biosimilar Revenue by Type (2016-2021) (US$ Million)
    Table 30. Global Trastuzumab Biosimilar Revenue Share by Type (2016-2021)
    Table 31. Trastuzumab Biosimilar Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
    Table 32. Global Trastuzumab Biosimilar Sales Forecast by Type (2022-2027) & (K Units)
    Table 33. Global Trastuzumab Biosimilar Sales Market Share Forecast by Type (2022-2027)
    Table 34. Global Trastuzumab Biosimilar Revenue Forecast V (2022-2027) & (US$ Million)
    Table 35. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Type (2022-2027)
    Table 36. Global Trastuzumab Biosimilar Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
    Table 37. Global Trastuzumab Biosimilar Sales by Application (2016-2021) (K Units)
    Table 38. Global Trastuzumab Biosimilar Sales Share by Application (2016-2021)
    Table 39. Global Trastuzumab Biosimilar Revenue by Application (2016-2021) (US$ Million)
    Table 40. Global Trastuzumab Biosimilar Revenue Share by Application (2016-2021)
    Table 41. Trastuzumab Biosimilar Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
    Table 42. Global Trastuzumab Biosimilar Sales Forecast by Application (2022-2027) & (K Units)
    Table 43. Global Trastuzumab Biosimilar Sales Market Share Forecast by Application (2022-2027)
    Table 44. Global Trastuzumab Biosimilar Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 45. Global Trastuzumab Biosimilar Revenue Market Share Forecast by Application (2022-2027)
    Table 46. Global Trastuzumab Biosimilar Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
    Table 47. United States Trastuzumab Biosimilar Sales (K Units) of Key Companies (2016-2021)
    Table 48. United States Trastuzumab Biosimilar Sales Share by Company (2016-2021)
    Table 49. United States Trastuzumab Biosimilar Revenue (US$ Million) by Company (2016-2021)
    Table 50. United States Trastuzumab Biosimilar Revenue Share by Company (2016-2021)
    Table 51. United States Trastuzumab Biosimilar Sales (K Units) by Type (2016-2021)
    Table 52. United States Trastuzumab Biosimilar Sales Share by Type (2016-2021)
    Table 53. United States Trastuzumab Biosimilar Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 54. United States Trastuzumab Biosimilar Price (US$/Unit) by Type (2016-2021)
    Table 55. United States Trastuzumab Biosimilar Sales (K Units) by Type (2022-2027)
    Table 56. United States Trastuzumab Biosimilar Sales Share by Type (2022-2027)
    Table 57. United States Trastuzumab Biosimilar Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 58. United States Trastuzumab Biosimilar Revenue Share by Type (2022-2027)
    Table 59. United States Trastuzumab Biosimilar Price (US$/Unit) by Type (2022-2027)
    Table 60. United States Trastuzumab Biosimilar Sales (K Units) by Application (2016-2021)
    Table 61. United States Trastuzumab Biosimilar Sales Share by Application (2016-2021)
    Table 62. United States Trastuzumab Biosimilar Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 63. United States Trastuzumab Biosimilar Price (US$/Unit) by Application (2016-2021)
    Table 64. United States Trastuzumab Biosimilar Sales (K Units) by Application (2022-2027)
    Table 65. United States Trastuzumab Biosimilar Sales Share by Application (2022-2027)
    Table 66. United States Trastuzumab Biosimilar Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 67. United States Trastuzumab Biosimilar Revenue Share by Application (2022-2027)
    Table 68. United States Trastuzumab Biosimilar Price (US$/Unit) by Application (2022-2027)
    Table 69. North America Trastuzumab Biosimilar Sales by Country (2016-2021) & (K Units)
    Table 70. North America Trastuzumab Biosimilar Sales Market Share by Country (2016-2021)
    Table 71. North America Trastuzumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
    Table 72. North America Trastuzumab Biosimilar Revenue Market Share by Country (2016-2021)
    Table 73. Asia Pacific Trastuzumab Biosimilar Sales by Region (2016-2021) & (K Units)
    Table 74. Asia Pacific Trastuzumab Biosimilar Sales Market Share by Region (2016-2021)
    Table 75. Asia Pacific Trastuzumab Biosimilar Revenue by Region (2016-2021) & (US$ Million)
    Table 76. Asia Pacific Trastuzumab Biosimilar Revenue Market Share by Region (2016-2021)
    Table 77. Europe Trastuzumab Biosimilar Sales by Country (2016-2021) & (K Units)
    Table 78. Europe Trastuzumab Biosimilar Sales Market Share by Country (2016-2021)
    Table 79. Europe Trastuzumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
    Table 80. Europe Trastuzumab Biosimilar Revenue Market Share by Country (2016-2021)
    Table 81. Latin America Trastuzumab Biosimilar Sales by Country (2016-2021) & (K Units)
    Table 82. Latin America Trastuzumab Biosimilar Sales Market Share by Country (2016-2021)
    Table 83. Latin Americaa Trastuzumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
    Table 84. Latin America Trastuzumab Biosimilar Revenue Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Trastuzumab Biosimilar Sales by Country (2016-2021) & (K Units)
    Table 86. Middle East and Africa Trastuzumab Biosimilar Sales Market Share by Country (2016-2021)
    Table 87. Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
    Table 88. Middle East and Africa Trastuzumab Biosimilar Revenue Market Share by Country (2016-2021)
    Table 89. Amgen Inc. Corporation Information
    Table 90. Amgen Inc. Description and Business Overview
    Table 91. Amgen Inc. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 92. Amgen Inc. Trastuzumab Biosimilar Product
    Table 93. Amgen Inc. Recent Development
    Table 94. Pfizer Inc Corporation Information
    Table 95. Pfizer Inc Description and Business Overview
    Table 96. Pfizer Inc Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 97. Pfizer Inc Product
    Table 98. Pfizer Inc Recent Development
    Table 99. Samsung Bioepis Corporation Information
    Table 100. Samsung Bioepis Description and Business Overview
    Table 101. Samsung Bioepis Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 102. Samsung Bioepis Product
    Table 103. Samsung Bioepis Recent Development
    Table 104. Merck & Co. Corporation Information
    Table 105. Merck & Co. Description and Business Overview
    Table 106. Merck & Co. Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 107. Merck & Co. Product
    Table 108. Merck & Co. Recent Development
    Table 109. Biocon Limited Corporation Information
    Table 110. Biocon Limited Description and Business Overview
    Table 111. Biocon Limited Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 112. Biocon Limited Product
    Table 113. Biocon Limited Recent Development
    Table 114. Teva Pharmaceutical Corporation Information
    Table 115. Teva Pharmaceutical Description and Business Overview
    Table 116. Teva Pharmaceutical Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 117. Teva Pharmaceutical Product
    Table 118. Teva Pharmaceutical Recent Development
    Table 119. Genentech Corporation Information
    Table 120. Genentech Description and Business Overview
    Table 121. Genentech Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 122. Genentech Product
    Table 123. Genentech Recent Development
    Table 124. Mundipharma Corporation Information
    Table 125. Mundipharma Description and Business Overview
    Table 126. Mundipharma Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 127. Mundipharma Product
    Table 128. Mundipharma Recent Development
    Table 129. Celltrion Corporation Information
    Table 130. Celltrion Description and Business Overview
    Table 131. Celltrion Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 132. Celltrion Product
    Table 133. Celltrion Recent Development
    Table 134. Henlius Corporation Information
    Table 135. Henlius Description and Business Overview
    Table 136. Henlius Trastuzumab Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 137. Henlius Product
    Table 138. Henlius Recent Development
    Table 139. Trastuzumab Biosimilar Market Trends
    Table 140. Trastuzumab Biosimilar Market Drivers
    Table 141. Trastuzumab Biosimilar Market Challenges
    Table 142. Trastuzumab Biosimilar Market Restraints
    Table 143. Trastuzumab Biosimilar Customers List
    Table 144. Trastuzumab Biosimilar Distributors List
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Trastuzumab Biosimilar Product Picture
    Figure 2. Global Trastuzumab Biosimilar Sales Market Share by Type in 2020 & 2027
    Figure 3. Adjuvant Breast Cancer Product Picture
    Figure 4. Metastatic Breast Cancer Product Picture
    Figure 5. Metastatic Gastric Cancer Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Trastuzumab Biosimilar Sales Market Share by Application in 2020 & 2027
    Figure 8. Hospital Pharmacy
    Figure 9. Online Pharmacy
    Figure 10. Trastuzumab Biosimilar Report Years Considered
    Figure 11. Global Trastuzumab Biosimilar Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Trastuzumab Biosimilar Market Size 2016-2027 (US$ Million)
    Figure 13. Global Trastuzumab Biosimilar Sales 2016-2027 (K Units)
    Figure 14. Global Trastuzumab Biosimilar Market Size Market Share by Region: 2021 Versus 2027
    Figure 15. Global Trastuzumab Biosimilar Sales Market Share by Region (2016-2021)
    Figure 16. Global Trastuzumab Biosimilar Sales Market Share by Region in 2020
    Figure 17. Global Trastuzumab Biosimilar Revenue Market Share by Region (2016-2021)
    Figure 18. Global Trastuzumab Biosimilar Revenue Market Share by Region in 2020
    Figure 19. Global Trastuzumab Biosimilar Sales Share by Manufacturer in 2020
    Figure 20. The Top 10 and 5 Players Market Share by Trastuzumab Biosimilar Revenue in 2020
    Figure 21. Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 22. Global Trastuzumab Biosimilar Sales Market Share by Type (2016-2021)
    Figure 23. Global Trastuzumab Biosimilar Sales Market Share by Type in 2020
    Figure 24. Global Trastuzumab Biosimilar Revenue Market Share by Type (2016-2021)
    Figure 25. Global Trastuzumab Biosimilar Revenue Market Share by Type in 2020
    Figure 26. Global Trastuzumab Biosimilar Sales Market Share by Application (2016-2021)
    Figure 27. Global Trastuzumab Biosimilar Sales Market Share by Application in 2020
    Figure 28. Global Trastuzumab Biosimilar Revenue Market Share by Application (2016-2021)
    Figure 29. Global Trastuzumab Biosimilar Revenue Market Share by Application in 2020
    Figure 30. United States Trastuzumab Biosimilar Sales Growth Rate 2016-2027 (K Units)
    Figure 31. United States Trastuzumab Biosimilar Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 32. United States Trastuzumab Biosimilar Market Share in Global Market 2016-2027
    Figure 33. United States 5 and 10 Largest Trastuzumab Biosimilar Players Market Share by Revenue in Trastuzumab Biosimilar in 2020
    Figure 34. United States Trastuzumab Biosimilar Revenue Share by Type (2016-2021)
    Figure 35. United States Trastuzumab Biosimilar Revenue Growth Rate by Type in 2016 & 2020
    Figure 36. United States Trastuzumab Biosimilar Revenue Share by Application (2016-2021)
    Figure 37. United States Trastuzumab Biosimilar Revenue Growth Rate by Application in 2016 & 2020
    Figure 38. North America Trastuzumab Biosimilar Sales Growth Rate 2016-2021 (K Units)
    Figure 39. North America Trastuzumab Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 40. North America Trastuzumab Biosimilar Sales Market Share by Country in 2020
    Figure 41. North America Trastuzumab Biosimilar Revenue Market Share by Country in 2020
    Figure 42. United States Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 43. United States Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 44. Canada Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 45. Canada Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 46. Europe Trastuzumab Biosimilar Sales Growth Rate 2016-2021 (K Units)
    Figure 47. Europe Trastuzumab Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 48. Europe Trastuzumab Biosimilar Sales Market Share by Country in 2020
    Figure 49. Europe Trastuzumab Biosimilar Revenue Market Share by Country in 2020
    Figure 50. Germany Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 51. Germany Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 52. France Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 53. France Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 54. U.K. Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 55. U.K. Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 56. Italy Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 57. Italy Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 58. Russia Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 59. Russia Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 60. Asia Pacific Trastuzumab Biosimilar Sales Growth Rate 2016-2021 (K Units)
    Figure 61. Asia Pacific Trastuzumab Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 62. Asia Pacific Trastuzumab Biosimilar Sales Market Share by Region in 2020
    Figure 63. Asia Pacific Trastuzumab Biosimilar Revenue Market Share by Region in 2020
    Figure 64. China Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 65. China Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 66. Japan Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 67. Japan Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 68. South Korea Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 69. South Korea Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 70. India Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 71. India Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 72. Australia Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 73. Australia Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 74. China Taiwan Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 75. China Taiwan Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 76. Indonesia Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 77. Indonesia Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 78. Thailand Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 79. Thailand Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 80. Malaysia Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 81. Malaysia Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 82. Latin America Trastuzumab Biosimilar Sales Growth Rate 2016-2021 (K Units)
    Figure 83. Latin America Trastuzumab Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 84. Latin America Trastuzumab Biosimilar Sales Market Share by Country in 2020
    Figure 85. Latin America Trastuzumab Biosimilar Revenue Market Share by Country in 2020
    Figure 86. Mexico Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 87. Mexico Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 88. Brazil Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 89. Brazil Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 90. Argentina Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 91. Argentina Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 92. Middle East and Africa Trastuzumab Biosimilar Sales Growth Rate 2016-2021 (K Units)
    Figure 93. Middle East and Africa Trastuzumab Biosimilar Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 94. Middle East and Africa Trastuzumab Biosimilar Sales Market Share by Country in 2020
    Figure 95. Middle East and Africa Trastuzumab Biosimilar Revenue Market Share by Country in 2020
    Figure 96. Turkey Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 97. Turkey Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 98. Saudi Arabia Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 99. Saudi Arabia Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 100. UAE Trastuzumab Biosimilar Sales Growth Rate (2016-2021) (K Units)
    Figure 101. UAE Trastuzumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 102. Trastuzumab Biosimilar Value Chain
    Figure 103. Channels of Distribution
    Figure 104. Distributors Profiles
    Figure 105. Bottom-up and Top-down Approaches for This Report
    Figure 106. Data Triangulation
    Figure 107. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc.
Pfizer Inc
Samsung Bioepis
Merck & Co.
Biocon Limited
Teva Pharmaceutical
Genentech
Mundipharma
Celltrion
Henlius
Frequently Asked Questions
Trastuzumab Biosimilar report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Trastuzumab Biosimilar report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Trastuzumab Biosimilar report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports